Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1756-2025

Bard Blakemore Esophageal-Nasogastric Tube (Adult) REF: 0092100 Recall

Bard Blakemore Esophageal-Nasogastric Tube (Adult) REF: 0092100

FDA recall Class I

Ongoing

FDA lists this Class I recall for Bard Blakemore Esophageal-Nasogastric Tube (Adult) REF: 0092100. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1756-2025
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Apr 17, 2025
FDA report date
May 28, 2025
Quantity in commerce
N/A
Distribution
See key details
FDA cause
Device Design

What is being recalled?

Bard Blakemore Esophageal-Nasogastric Tube (Adult) REF: 0092100

Affected model & UDI checker

Search the exact identifiers published for Z-1756-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
0092100Bard Blakemore Esophageal-Nasogastric Tube (Adult) REF: 0092100Check source noticeNot specified
Not specifiedBard Blakemore Esophageal-Nasogastric Tube (Adult) REF: 0092100Check source notice00801741076800
FDA code information

All Lots within expiration/UDI: (01)00801741076800

View the original FDA recall notice

Why was this product recalled?

Due to customer complaints, there is a potential for users to be unable to or find it difficult to remove the plastic plugs in order to inflate the gastric and/or esophageal balloons.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did C.R. Bard, Inc. take?

On April 17, 2025, BD (C.R. Bard) Urology and Critical Care issued a "Urgent Medical Device Correction" Notification to affected consignees. BD asked consignees to take the following actions: 1. Follow the above plastic plug removal instructions. 2. Post this notice where the devices are stored. 3. Please check all inventory locations within your institution for affected products 4. Share this notice with any users of the product within your facilities or with any interfacility users where product was transferred 5.Complete and return the attached Customer Response Form to the BD contact noted on the form confirming acknowledgement of this notification 6.Report any adverse health consequences experienced with the use of this product to BD. Events may also be reported to the FDA's MedWatch Adverse Event Reporting program via: Web: MedWatch website at www.fda.gov/medwatch Phone: 1-800-FDA-1088 (1-800-332-1088)

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology